Market Overview

Voyager Therapeutics (NASDAQ: VYGR)

10.71 -0.40 (-3.60%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.66
18.067M



Q4 2020
After-Hours
EPS:
REV:
-0.34
32.674M



Q3 2020
Pre-Market
EPS:
REV:
-0.41
20.433M



Q2 2020
Pre-Market
EPS:
REV:
0.29
46.087M
-0.72
15.52M
-0.23
28.681M
68.06%
84.8%
Q1 2020
Pre-Market
EPS:
REV:
-0.81
5.197M

-0.66
18.067M

Q4 2019
After-Hours
EPS:
REV:
-0.70
2.008M
-0.81
10.92M
-0.34
32.674M
58.02%
199.21%
Q3 2019
Pre-Market
EPS:
REV:
-0.63
2.094M
-0.76
7.64M
-0.41
20.433M
46.05%
167.45%
Q2 2019
Pre-Market
EPS:
REV:
-0.80
2.575M

7.64M
0.29
46.087M

503.23%
Q1 2019
Pre-Market
EPS:
REV:
-0.63
942K
0.58
48.28M
-0.81
5.197M
-239.66%
-89.24%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!